Botox and Detrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Botox (botulinum toxin type a) and Detrol (tolterodine tartrate). Common drug interactions include peripheral ischaemia among females and body temperature increased among males.

The phase IV clinical study analyzes what interactions people have when they take Botox and Detrol. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Botox?

Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,513 Botox users. Check the latest studies of Botox.

What is Detrol?

Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,669 Detrol users. Check the latest studies of Detrol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

47 people who take Botox and Detrol together, and have interactions are studied.

Botox and Detrol drug interactions.

What are the common drug interactions of Botox and Detrol, by gender? *:

female:

  1. Peripheral ischaemia (impaired circulation to an extremity)
  2. Rectal prolapse (falling of rectum from normal place)
  3. Sinusitis (inflammation of sinus)
  4. Swelling
  5. Swelling face
  6. Tooth extraction
  7. Uterovaginal prolapse
  8. Wound decomposition
  9. Wound secretion
  10. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)

male:

  1. Body temperature increased
  2. Drug ineffective
  3. Burning sensation
  4. Crying
  5. Dehydration (dryness resulting from the removal of water)
  6. Depression
  7. Dysuria (painful or difficult urination)
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Insomnia (sleeplessness)

What are the common drug interactions of Botox and Detrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Aphthous ulcer (mouth ulcer)
  3. Asthenia (weakness)
  4. Back pain
  5. Bacterial test positive
  6. Balance disorder
  7. Body temperature increased
  8. Burning sensation
  9. Crying
  10. Dehydration (dryness resulting from the removal of water)

30-39:

  1. Body temperature increased
  2. Drug intolerance (drug sensitivity)
  3. Feeling of body temperature change
  4. Nausea (feeling of having an urge to vomit)

40-49:

  1. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  4. Rash
  5. Rash pruritic (redness with itching)
  6. Road traffic accident
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. White blood cell count increased
  9. Arthralgia (joint pain)
  10. Back pain

50-59:

  1. Injection site pain
  2. Fall
  3. Loss of consciousness
  4. Respiratory fume inhalation disorder (the problem of respiratory irritants and inhaled toxic)

60+:

  1. Fall
  2. Headache (pain in head)
  3. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  4. Bone disorder
  5. Bone fistula
  6. Cardiac failure congestive
  7. Carotid artery stenosis (narrowing of carotid artery)
  8. Cellulitis (infection under the skin)
  9. Cerebral atrophy (decrement in size of brain)
  10. Chronic inflammatory demyelinating polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 27.66%
  2. Pain: 12 people, 25.53%
  3. Sleep Disorder: 10 people, 21.28%
  4. Muscle Spasms (muscle contraction): 9 people, 19.15%
  5. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 8 people, 17.02%
  6. Neuralgia (pain in one or more nerves): 7 people, 14.89%
  7. Urinary Tract Infection: 6 people, 12.77%
  8. Urinary Tract Infection Bacterial: 5 people, 10.64%
  9. Fatigue (feeling of tiredness): 5 people, 10.64%
  10. Gait Disturbance: 5 people, 10.64%

* Approximation only. Some reports may have incomplete information.

Do you take Botox and Detrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Botox and Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Botox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Botox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Detrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on botulinum toxin type a and tolterodine tartrate (the active ingredients of Botox and Detrol, respectively), and Botox and Detrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: